Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$179.30
-0.74%
Mkt Cap $138.35B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 21, 2026 | $5.98B | $5.95B | -0.51% | $1.94 | $2.06 | +6.19% | — | — |
| Q1 2026 Jan 28, 2026 | $6.81B | $6.84B | +0.40% | $2.16 | $2.23 | +3.24% | — | — |
| Q4 2025 Oct 21, 2025 | $6.00B | $6.05B | +0.92% | $1.72 | $1.89 | +9.88% | — | — |
| Q3 2025 Jul 22, 2025 | $5.84B | $5.94B | +1.68% | $1.64 | $1.80 | +9.76% | — | — |
| Q2 2025 Apr 22, 2025 | $5.57B | $5.74B | +3.04% | $1.63 | $1.88 | +15.34% | — | — |
| Q1 2025 Jan 29, 2025 | $6.45B | $6.54B | +1.44% | $2.14 | $2.14 | +0.00% | — | — |
| Q4 2024 Oct 22, 2024 | $5.59B | $5.80B | +3.78% | $1.57 | $1.71 | +8.92% | — | — |
| Q3 2024 Jul 23, 2024 | $5.59B | $5.74B | +2.82% | $1.57 | $1.72 | +9.55% | — | — |
| Q2 2024 Apr 23, 2024 | $5.62B | $5.80B | +3.09% | $1.72 | $1.92 | +11.63% | — | — |
| Q1 2024 Jan 30, 2024 | $5.59B | $2.69B | -51.86% | $1.90 | $2.09 | +10.00% | — | — |
| Q4 2023 Oct 24, 2023 | $6.63B | $6.87B | +3.60% | $1.83 | $2.02 | +10.38% | — | — |
| Q3 2023 Jul 25, 2023 | $6.34B | $7.16B | +12.85% | $2.00 | $2.05 | +2.50% | — | — |
| Q2 2023 Apr 25, 2023 | $7.02B | $7.17B | +2.03% | $2.25 | $2.36 | +4.89% | — | — |
| Q1 2023 Jan 24, 2023 | $7.90B | $8.37B | +5.94% | $2.54 | $2.87 | +12.99% | — | — |
| Q4 2022 Oct 20, 2022 | $7.16B | $7.66B | +7.10% | $2.26 | $2.56 | +13.27% | — | — |
| Q3 2022 Jul 21, 2022 | $7.30B | $7.75B | +6.23% | $2.35 | $2.76 | +17.45% | — | — |
| Q2 2022 Apr 21, 2022 | $7.55B | $7.69B | +1.89% | $2.66 | $2.76 | +3.76% | — | — |
| Q1 2022 Jan 27, 2022 | $7.92B | $8.15B | +2.91% | $2.54 | $2.69 | +5.91% | — | — |
| Q4 2021 Oct 21, 2021 | $6.99B | $7.23B | +3.42% | $2.14 | $2.39 | +11.68% | — | — |
| Q3 2021 Jul 22, 2021 | $6.99B | $7.22B | +3.30% | $2.05 | $2.46 | +20.00% | — | — |